UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 23, 2022
Accession Number:
0001493152-22-007456
Submission Type:
POS AM
CIK:
0001857044
Company Name:
Indaptus Therapeutics, Inc.
File Number:
333-259771